Mustang Bio (MBIO)

• Market cap: $5.27M
• 1 day: -4.26%
• 5 days: -8.42%
• 1 month: -7.2%
• 3 months: -15.81%
• 6 months: -43.41%
• Year to date: -34.95%
• 1 year: -41.02%
• 5 years: -99.97%
• 10 years: -99.99%
• Sector: Healthcare
• Industry: Biotechnology

About: Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs into potential cures for difficult-to-treat cancers. It acquires rights to these technologies by licensing or otherwise acquiring an ownership interest in the technologies, funding their research and development, and eventually either out-licensing or bringing the technologies to market. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.

Employees: 4